Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular histoplasmosis syndrome.

D B Burgess

    Ophthalmology
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Argon laser photocoagulation significantly reduces severe vision loss in ocular histoplasmosis patients with choroidal neovascular membranes. Prompt treatment is recommended for those with membranes outside the fovea.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome.

    Retina (Philadelphia, Pa.)·1996
    Same author

    Macular disease resembling adult foveomacular vitelliform dystrophy in older adults.

    Ophthalmology·1987
    Same author

    Neovascular glaucoma: a retrospective analysis of treatment with peripheral panretinal cryotherapy.

    Ophthalmic surgery·1987
    Same author

    Factors related to spontaneous visual recovery in the ocular histoplasmosis syndrome.

    Retina (Philadelphia, Pa.)·1987
    Same author

    Pseudophakic retinal detachments in the presence of various IOL types.

    Ophthalmology·1986
    Same author

    Treatment of recurrent juxtafoveal subretinal neovascular membranes with krypton red laser photocoagulation.

    Ophthalmology·1985

    Area of Science:

    • Ophthalmology
    • Retinal Diseases
    • Medical Interventions

    Background:

    • Choroidal neovascular membranes (NVMs) can cause severe vision loss.
    • Ocular histoplasmosis syndrome is a common cause of NVMs.
    • Treatment options for NVMs not involving the fovea were previously limited.

    Purpose of the Study:

    • To evaluate the efficacy of argon laser photocoagulation for NVMs outside the fovea.
    • To compare laser treatment outcomes with observation in patients with ocular histoplasmosis.

    Main Methods:

    • The Macular Photocoagulation Study (MPS) was a multi-center clinical trial.
    • Patients with ocular histoplasmosis and extrafoveal NVMs were randomized to receive argon laser photocoagulation or no treatment.
    • Visual acuity and other measures of vision were monitored over two years.

    Related Experiment Videos

    Main Results:

    • Argon laser photocoagulation reduced the risk of severe visual loss from 46% to 13% within two years.
    • The treatment was particularly effective in patients with ocular histoplasmosis syndrome.
    • No significant adverse effects of the laser treatment were reported.

    Conclusions:

    • Argon laser photocoagulation is an effective treatment for NVMs that do not involve the fovea, especially in patients with ocular histoplasmosis.
    • Prompt treatment with argon laser photocoagulation is advised for eligible patients.
    • The MPS findings support the use of laser photocoagulation as a standard of care.